433926-47-7 Usage
Uses
Used in Pharmaceutical Industry:
(3-CHLORO-5-(TRIFLUOROMETHOXY)PHENYL)METHANOL is used as an intermediate in organic synthesis for the production of various pharmaceuticals. Its unique structure contributes to the development of novel drugs with potential therapeutic applications.
Used in Agrochemical Industry:
In the agrochemical sector, (3-CHLORO-5-(TRIFLUOROMETHOXY)PHENYL)METHANOL is utilized as an intermediate in the synthesis of agrochemicals, which are essential for enhancing crop protection and productivity.
Used in Specialty Chemicals Production:
(3-CHLORO-5-(TRIFLUOROMETHOXY)PHENYL)METHANOL is also employed as an intermediate in the production of specialty chemicals, which have a wide range of applications in various industries.
Used in Polymer Industry:
This chemical compound serves as an intermediate in the synthesis of specific polymers, which are used in the manufacturing of materials with unique properties and applications.
Used in Dye Industry:
(3-CHLORO-5-(TRIFLUOROMETHOXY)PHENYL)METHANOL is used as an intermediate in the production of dyes, contributing to the creation of vibrant and stable colorants for various applications.
Safety Note:
Although (3-CHLORO-5-(TRIFLUOROMETHOXY)PHENYL)METHANOL is considered to have low toxicity, it is crucial to handle it with care and follow appropriate safety measures during its use in any application.
Check Digit Verification of cas no
The CAS Registry Mumber 433926-47-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 4,3,3,9,2 and 6 respectively; the second part has 2 digits, 4 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 433926-47:
(8*4)+(7*3)+(6*3)+(5*9)+(4*2)+(3*6)+(2*4)+(1*7)=157
157 % 10 = 7
So 433926-47-7 is a valid CAS Registry Number.
433926-47-7Relevant academic research and scientific papers
Mandelic acid derivatives and their use as throbin inhibitors
-
Page/Page column 19, (2008/06/13)
There is provided a compound of formula I wherein Ra, R1, R2, Y and R3 have meanings given in the description and pharmaceutically acceptable derivatives (including prodrugs) thereof, which compounds and derivatives are useful as, or are useful as prodrugs of, competitive inhibitors of trypsin-like proteases, such as thrombin, and thus, in particular, in the treatment of conditions where inhibition of thrombin is required (e.g. thrombosis) or as anticoagulants.
PHARMACEUTICAL COMBINATION
-
Page 48; 49, (2010/02/04)
There is provided a combination product comprising: (1) a compound of claim 1 in WO 02/44145 or a compound of claim 20 in WO 02/44145 (or derivative thereof)or a pharmaceutically-acceptable derivative thereof; and (1) a compound as defined in claim 1 of WO 01/28992 or (2) a compound of Claim 34 of WO 01/28992 or (3) Compound A or B or C or D (or pharmaceutically-acceptable salts thereof) for use in treating arrhythmia or a coagulation controlled complication thereof.
